Interferon γ(IFNγ) gene transfer of an EMT6 tumor that is poorly responsive to IFNγ stimulation: Increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC

Cancer Immunology, Immunotherapy

Volumn 42, Issue 2, 1996, Pages 99-107

  Panelli, Monica C ^a   Wang, Ena ^a   Shen, Shanxiang ^a   Schluter, Samuel F ^a   Bernstein, Ralph M ^a   Hersh, Evan M ^b   Stopeck, Alison ^b   Gangavalli, Ramarao ^c   Barber, Jack ^c   Jolly, Douglas ^c   Akporiaye, Emmanuel T ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c Viagene Inc   (United States)

Author keywords

Class II transactivator (CIITA); EMT6; Gene therapy; Interferon ; MHC

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS VECTOR;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL DIVISION; EXPERIMENTAL MELANOMA; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SECRETION; STIMULATION; ANIMAL EXPERIMENT; BREAST TUMOR; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; TUMOR IMMUNITY;

ANIMALS; BASE SEQUENCE; CELL DIVISION; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNITY, NATURAL; INTERFERON TYPE II; MAMMARY NEOPLASMS, EXPERIMENTAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; STIMULATION, CHEMICAL; TRANS-ACTIVATORS;

EID: 0029664652     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050258     Document Type: Article

References (27)

1. + tumor-infiltrating lymphocytes. J Exp Med 173:647
2. Baskar S, Nabavi N, Glimcher R, Ostrand-Rosenberg S (1993) Tumor cells expressing major histocompatibility class II and B7 activation molecules stimulate potent tumor specific immunity. J Immunother 14:209
3. Bateman WJ, Fiera R, Matthews N, and Morris AG (1991) Inducibility of class II major histocompatibility complex antigens by IFN-γ is associated with reduced tumorigenicity in C3H mouse fibroblasts transformed by V-Ki-ras. J Exp Med 173:193
4. Chang GH, Fontes JD, Petrlin M, Flavell RA (1994) Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 180:1367
5. Clements VK, Baskar S, Armstrong TD, Ostrand-Rosenberg S (1992) Invariant chain alters the malignant phenotype of MHC class II tumor cells. J Immunol 149:2391
6. Darnell J Jr, Kerr IM, Stark GR (1994) Jak-Stat pathways and transcriptional activation in response to the IFNs and other extracellular signaling proteins. Science 264:1415
7. Gansbacher B, Bannerji R, Daniels B, Zier K, Cronin K, Gilboa E (1990) Retroviral vector mediated γ-interferon gene transfer into tumor cells generates potent and long lasting tumor immunity. Cancer Res 50:7820
8. Gansbacher B, Zier K, Cronin K, Hantzopoulos PA, Bouchard B, Houghton A, Gilboa E, Golde D (1992) Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-γ in irradiated human melanoma cells. Blood 80:2817
9. Gastl G, Finslad CL, Guarini A, Bosl G, Gilboa E, Bander NH, Gansbacher B (1992) Retroviral vector mediated lymphokine gene transfer into human renal cancer cells. Cancer Res 52:6229
10. Germain RN (1993) The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 11:403
11. Goodenow RS, Vogel GM, Linsk RL (1985) Histocompatibility antigens on murine tumors. Science 230:777
12. Hammerling GJ, Klar D, Pulm V, Momburg F, Moldenhauer G (1987) The influence of major histocompatibility complex class I antigens on tumor growth and metastasis. Biochim Biophys Acta 907:245
13. Hosmer DW, Lemeshow S (1989) Applied logistic regression. Wiley, New York
14. Ogasawara M, Rosenberg SA (1993) Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with γ-interferon genes. Cancer Res 53:3561
15. Ostrand-Rosenberg S, Thakur O, Clements V (1990) Rejection of mouse sarcoma cells after transfection of MHC class II genes. J Immunol 144:4068
16. b gene. Proc Natl Acad Sci USA 85:4463
17. + T cells against the wild type tumor: correlation with antigen presentation capability. J Exp Med 175:1423
18. Riley J, Westerheide SD, Price JA, Brown JA, Boss JM (1995) Activation of class II MHC genes requires both the X box region and the class II transactsvator (CIITA). Immunity 2:533
19. Roux KH (1994) Using mismatched primer template pairs in touchdown PCR. Biotechniques 16:812
20. Sanceau J, Sondermayer P, Beranger F, Falcoff R, Vaquero C (1987) Intracellular human y-interferon triggers an antiviral state in transformed murine L cells. Immunology 84:2906
21. Shiloni E, Karp SE, Custer MC, Shilyansky J, Restifo NP, Rosenberg SA, Mulé JJ (1993) Retroviral transduction of IFNγ cDNA into a non immunogenic murine fibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor. Cancer Immunol Immunother 37:286
22. Smith MR, Muegge K, Keller JR, Kung JF, Young HA, Durum SK (1990) Direct evidence for an intracellular role for IFNγ. Microinjection of human IFNγ induces Ia expression in murine macrophages. J Immunol 144:1777
23. Steimle V, Siegrist CA, Mottet A, Lisowwska-Grospierre B, Mach B (1994) Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265:106
24. Steimie V, Otten LA, Zufferey M, Mach B (1993) Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135
25. Tuttle TM, McCrady CW, Inge TH, Salour M, Bear HD (1993) γ-Interferon plays a key role in T-cell-induced tumor regression. Cancer Res 53:833
26. Watanabe Y, Kuribayashi K, Miyatake S, Nishihara K, Nakayama E, Taniyama T, Sakata T (1989) Exogenous expression of mouse IFN-γ cDNA in mouse neuroblastoma C 1300 cells result in reduced tumorigenicity by augmented antitumor immunity. Proc Natl Acad Sci USA 86:9456
27. Zhou H, Glimcher LH (1995) Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immunodeficiency. Cell 2:545